Utama › Kanser (semua jenis) › Illinois › Chicago
Kajian klinikal Kanser (semua jenis) di Chicago, IL
51 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Mengambil pesertaFasa 1
- University of Chicago Medical Center /ID# 278863, Chicago
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Mengambil pesertaKajian pemerhatian
- Northwestern University, Chicago
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Mengambil pesertaFasa 3
- Investigative Site, Chicago
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Mengambil pesertaFasa 3
- University of Illinois Chicago, Chicago
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Mengambil pesertaFasa 3
- Northwestern Memorial Hospital, Chicago
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
- University of Chicago Medical Center /ID# 280149, Chicago
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- Cancer Treatment Centers of America-Chicago, Chicago
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- Northwestern Memorial Hospital, Chicago
- University Of Chicago Medical Center, Chicago
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Mengambil pesertaFasa 2
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Mengambil peserta
- Northwestern Memorial Hospital, Chicago
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Mengambil peserta
- Advocate Illinois Masonic Medical Center, Chicago
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Mengambil pesertaFasa 1
- Northwestern University ( Site 0101), Chicago
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- University of Chicago, Chicago
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Mengambil pesertaFasa 3
- Insight Research Institute, Chicago
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaKajian pemerhatian
- Northwestern University Feinberg School of Medicine, Chicago
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
Mengambil pesertaKajian pemerhatian
- Ann &Robert H Lurie Children's Hospital, Chicago
Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Mengambil pesertaKajian pemerhatian
- Ann & Robert H Lurie Childrens Hospital, Chicago
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- Northwestern University, Chicago
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- University of Illinois, Chicago
- dan 1 lagi
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Mengambil pesertaFasa 3
- University of Chicago, Chicago
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Site 05, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Mengambil pesertaFasa 1/2
- University of Chicago Medical Center, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Tempus AI, Chicago
International Rare Brain Tumor Registry
Mengambil pesertaKajian pemerhatian
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Mengambil pesertaFasa 2
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- dan 1 lagi
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Mengambil pesertaFasa 2
- Lurie Children's Hospital, Chicago
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Chicago Medicine, Chicago
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Mengambil pesertaFasa 2
- University of Chicago Medical Center /ID# 274742, Chicago
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Mengambil peserta
- Northwestern University, Chicago
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Mengambil peserta
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Molecular Genetics Studies of Cancer Patients and Their Relatives
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- John H Stroger Jr Hospital of Cook County, Chicago
- Rush University Medical Center, Chicago
Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program
Mengambil pesertaSukarelawan sihat dialu-alukan
- Northwestern University, Chicago
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Ana & Robert H. Lurie Children's Hospital of Chicago, Chicago
- University of Chicago, Chicago
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Mengambil pesertaFasa 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Mengambil pesertaFasa 1
- Context Investigational Site, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Mengambil pesertaFasa 1/2
- Northwestern Memorial Hospital, Chicago
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Mengambil pesertaKajian pemerhatian
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
Mengambil peserta
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Mengambil pesertaFasa 1/2
- University of Chicago, Chicago
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- University of Chicago Medical Center, Chicago
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Mengambil pesertaFasa 1/2
- Northwestern Memorial Hospital, Chicago
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Mengambil peserta
- University of Chicago Medicine, Chicago
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Chicago
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Mengambil pesertaFasa 1
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- University of Chicago, Chicago
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- Advocate Illinois Masonic Medical Center, Chicago
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Mengambil pesertaKajian pemerhatian
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
- St. Louis, MO46 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kanser Kolorektal33 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.